openPR Logo
Press release

Global Pet Cancer Therapeutics Market Projected to Surpass $0.65 Billion by 2029 with 11% Annual Growth

Global Pet Cancer Therapeutics Market Projected to Surpass

How Are the key drivers contributing to the expansion of the pet cancer therapeutics market?
The augmentation in the amount expended on pet healthcare is anticipated to stimulate the expansion of the pet cancer therapeutics market in the future. This spend entails the costs on veterinary services, medication, and other health-related necessities for pets. The observed surge in healthcare expenditure for pets is an indicator of pet owners' increasing readiness to invest in their pets' health, thereby potentially fuelling the demand for pet cancer treatments. The 2023 State of the Industry Report by the North American Pet Health Insurance Association (NAPHIA), a US pet health insurance group, revealed a telling 22% increase in insured pets in the US, reaching 4.8 million by the end of 2022, as compared to the previous year. Therefore, the escalating outlay on pet healthcare is what's propelling the pet cancer therapeutics market.

Get Your Pet Cancer Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/pet-cancer-therapeutics-global-market-report

What growth opportunities are expected to drive the pet cancer therapeutics market's CAGR through 2034?
The market size of animal cancer treatments has expanded swiftly in the past few years. This progression is expected to continue, growing from $0.39 billion in 2024 to $0.43 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. The historic period's expansion can be credited to factors such as the increase in pet ownership, developments in veterinary science, heightened consciousness about pet wellness, treating pets more humanely, and the broadening scope of veterinary services.

In the coming years, the pet cancer therapeutics market is anticipated to experience a swift expansion. It is projected to increase to $0.65 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 10.7%. The expected growth within the forecast period is linked to factors such as the rising elderly pet population, advancements made in cancer treatments, an increase in veterinary oncology services, pet insurance and healthcare plans, and the global proliferation of pet care services. Key trends forecasted for this period encompass a surge in nutraceuticals and integrative therapies, enhanced availability of targeted diagnostic tests, collaboration between veterinary and human oncology sectors, the release of innovative chemotherapeutic agents, and the growth in awareness and education of pet owners.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9984&type=smp

What are the emerging trends shaping the future of the pet cancer therapeutics market?
Leading firms in the pet cancer therapeutics sector are adopting cutting-edge technologies such as epigenetics to augment the accuracy and effectiveness of cancer treatment, thereby bettering prognosis for pets diagnosed with cancer. Epigenetic technology pertains to techniques that alter gene behavior without affecting the basic DNA structure, often impacting cellular conduct and potential treatment consequences. For instance, in April 2024, a international epigenetics firm based in the United States named VolitionRx Limited introduced the Nu.Q Vet Cancer Test. The test is run on the Element i+ Analyzer and provides speedy results, typically in around 6 minutes. It employs an enzyme-linked immunosorbent assay to identify circulating nucleosomes in the bloodstream, which could signify cancer's presence.

Which growth-oriented segments of the pet cancer therapeutics market are leading the industry's development?
The pet cancer therapeutics market covered in this report is segmented -

1) By Cancer Type: Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer
2) By Species: Dogs, Cats, Other Species
3) By Therapy: Chemotherapy, Radiation Therapy, Immunotherapy, TomoTherapy, Other Therapies
4) By End User: Veterinary Hospitals, Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, Other End Users

Subsegments:
1) By Melanoma: Surgical Interventions, Chemotherapy, Immunotherapy, Targeted Therapy
2) By Mast Cell Cancer: Surgery, Chemotherapy, Tyrosine Kinase Inhibitors, Radiation Therapy
3) By Lymphoma: Chemotherapy Protocols, Steroid Therapy, Radiation Therapy, Immunotherapy
4) By Mammary And Squamous Cell Cancer: Surgical Treatment, Chemotherapy, Radiation Therapy, Palliative Care Options

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9984

What regions are leading the charge in the pet cancer therapeutics market?
North America was the largest region in the pet cancer therapeutics market in 2024. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What companies are at the forefront of innovation in the pet cancer therapeutics market?
Major companies operating in the pet cancer therapeutics market include AB Science, Boehringer Ingelheim GmbH, Elanco Animal Health, ELIAS Animal Health, Zoetis Inc., Anivive Lifesciences Inc., QBiotics Group Ltd., Regeneus Ltd., VetDC Inc., PetCure Oncology at Veterinary Radiosurgery and Imaging Center, Torigen Pharmaceuticals Inc., virology and bacteriology, Nippon Zenyaku Kogyo Co. Ltd., Vivesto AB, Dechra Pharmaceuticals plc, Norbrook Laboratories Ltd., AdvaVet Inc., Oasmia Pharmaceuticals AB, Zenoaq Co. Ltd., Morphogenesis Inc., Sumitomo Pharma Animal Health Co., Vetivax, CarthroniX Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9984&type=smp

What Is Covered In The Pet Cancer Therapeutics Global Market Report?

• Market Size Forecast: Examine the pet cancer therapeutics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the pet cancer therapeutics market for a structured understanding.
• Key Players Overview: Analyze major players in the pet cancer therapeutics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pet cancer therapeutics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the pet cancer therapeutics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pet cancer therapeutics market.
• Industry Challenges: Identify potential risks and obstacles affecting the pet cancer therapeutics market.
• Competitive Landscape: Review strategic developments in the pet cancer therapeutics market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pet Cancer Therapeutics Market Projected to Surpass $0.65 Billion by 2029 with 11% Annual Growth here

News-ID: 3893064 • Views:

More Releases from The Business Research Company

Global High-Resolution Anoscopy Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
Global High-Resolution Anoscopy Market Outlook 2025-2034: Trends, Innovations, A …
The High-Resolution Anoscopy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the High-Resolution Anoscopy Market Size and Projected Growth Rate? The market size for high-resolution anoscopy has experienced significant growth over the past few years. The market is predicted to increase from $15.03 billion
Condyloma Acuminata Treatment Market Size Projected To Reach $2.2 Billion By 2034 With A Cagr Of 4%
Condyloma Acuminata Treatment Market Size Projected To Reach $2.2 Billion By 203 …
"The Condyloma Acuminata Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Condyloma Acuminata Treatment Market Size During the Forecast Period? In the past few years, the condyloma acuminata treatment market has seen significant growth. The market value, which is anticipated to
Household Type Fans Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Household Type Fans Market Forecast 2025-2034: Comprehensive Analysis And Growth …
"The Household Type Fans Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Household Type Fans Market? The market size for household fans has seen consistent expansion in recent years. The projections indicate an increase from $32.22 billion in 2024
Grain Fumigants Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Grain Fumigants Industry Report 2025-2034: Market Dynamics, Trends, And Forecast …
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Grain Fumigants Market Size During the Forecast Period? The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For